Search research articles
Contact Us
Filters
Showing results (181-190 of 1,845) with videos related to
Page
of 185
Sort By:
Human Reproduction (Oxford, England)
|
August 7, 1999
The effects of group size on development and interferon-tau secretion by in-vitro fertilized and cultured bovine blastocysts
M A Larson, H M Kubisch
Biotechniques
|
August 1, 1993
Applications of the ChromaPhor Protein Recovery System
G A Larson, J W Shultz
European Journal of Pharmacology
|
July 6, 1993
Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice
J S Kreeger, A A Larson
European Journal of Pharmacology
|
April 11, 1997
Zn2+ inhibition of [3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate
K J Kovács, A A Larson
European Journal of Pharmacology
|
October 16, 1995
Discrepancies in characterization of sigma sites in the mouse central nervous system
K J Kovács, A A Larson
Rheumatic Diseases Clinics of North America
|
August 4, 2009
Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis
I Jon Russell, Alice A Larson
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Is a fourth year necessary in radiation oncology training? Different models and funding mechanisms
D A Larson, T L Phillips
Seminars in Oncology
|
August 12, 2008
Therapy-related myeloid leukemia
Lucy A Godley, Richard A Larson
Rural and Remote Health
|
August 16, 2008
The future, our rural populations and climate change--a special issue of Rural and Remote Health
P Jones, A Larson, I Couper
Journal of Drugs in Dermatology : JDD
|
September 4, 2007
Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser
April A Larson, Mitchel P Goldman
Page
of 185
Search research articles
Search
Showing results (181-190 of 1,845) with videos related to
Sort By:
Page
of 185
Human Reproduction (Oxford, England)
|
August 7, 1999
The effects of group size on development and interferon-tau secretion by in-vitro fertilized and cultured bovine blastocysts
M A Larson, H M Kubisch
Biotechniques
|
August 1, 1993
Applications of the ChromaPhor Protein Recovery System
G A Larson, J W Shultz
European Journal of Pharmacology
|
July 6, 1993
Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice
J S Kreeger, A A Larson
European Journal of Pharmacology
|
April 11, 1997
Zn2+ inhibition of [3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate
K J Kovács, A A Larson
European Journal of Pharmacology
|
October 16, 1995
Discrepancies in characterization of sigma sites in the mouse central nervous system
K J Kovács, A A Larson
Rheumatic Diseases Clinics of North America
|
August 4, 2009
Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis
I Jon Russell, Alice A Larson
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Is a fourth year necessary in radiation oncology training? Different models and funding mechanisms
D A Larson, T L Phillips
Seminars in Oncology
|
August 12, 2008
Therapy-related myeloid leukemia
Lucy A Godley, Richard A Larson
Rural and Remote Health
|
August 16, 2008
The future, our rural populations and climate change--a special issue of Rural and Remote Health
P Jones, A Larson, I Couper
Journal of Drugs in Dermatology : JDD
|
September 4, 2007
Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser
April A Larson, Mitchel P Goldman
Page
of 185